Merrimack Pharmaceuticals
MACK
#7999
Rank
โ‚น19.14 B
Marketcap
โ‚น1,294
Share price
0.00%
Change (1 day)
5.28%
Change (1 year)

Earnings for Merrimack Pharmaceuticals (MACK)

Earnings in 2024 (TTM): -โ‚น0.19 Billion

According to Merrimack Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -โ‚น0.19 Billion a decrease over its 2022 earnings that were of -โ‚น0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Merrimack Pharmaceuticals from 2010 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚น0.19 Billion0.69%
2023 -โ‚น0.19 Billion0.09%
2022 -โ‚น0.19 Billion-16.9%
2021 -โ‚น0.23 Billion-49.89%
2020 -โ‚น0.45 Billion-75.39%
2019 -โ‚น1.82 Billion-68.58%
2018 -โ‚น5.78 Billion-19.4%
2017 -โ‚น7.17 Billion-36.46%
2016 -โ‚น11.28 Billion2.54%
2015 -โ‚น11 Billion96.78%
2014 -โ‚น5.59 Billion-45.44%
2013 -โ‚น10.25 Billion
2010 -โ‚น3.98 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚น679.44 B-351,673.26%๐Ÿ‡ซ๐Ÿ‡ท France
-โ‚น2.49 Billion 1,185.48%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น13.36 Billion 6,808.72%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น18.6 Billion 9,523.90%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น3.24 Billion 1,571.40%๐Ÿ‡บ๐Ÿ‡ธ USA